Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
5(100.0%)
5Total
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00479895Phase 2Completed

Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

Role: lead

NCT00317512Phase 2Completed

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Role: lead

NCT00300040Phase 2Terminated

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

Role: lead

NCT00301535Phase 2Unknown

A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery

Role: lead

NCT00301483Phase 2Unknown

A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects

Role: lead

All 5 trials loaded